New Leaf Biopharma Opportunities II, L.P.

Director at Harpoon Therapeutics, Inc. · on record since Mar 11, 2024
10% owner at Principia Biopharma Inc. · on record since Sep 20, 2018
10% owner at Harpoon Therapeutics, Inc. · on record since Feb 14, 2019

Insider trading activity of New Leaf Biopharma Opportunities II, L.P.

No transactions on record for New Leaf Biopharma Opportunities II, L.P..

Track record of New Leaf Biopharma Opportunities II, L.P.

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of New Leaf Biopharma Opportunities II, L.P.

Co-insiders of New Leaf Biopharma Opportunities II, L.P.

Colowick AlanHarpoon Therapeutics, Inc. +1
New Leaf BPO Associates II, L.P.Harpoon Therapeutics, Inc. +1
New Leaf BPO Management II, L.L.CHarpoon Therapeutics, Inc. +1
AKKARAJU SRINIVASPrincipia Biopharma Inc.
Arix Bioscience Holdings LtdHarpoon Therapeutics, Inc.
Arix Bioscience plcHarpoon Therapeutics, Inc.
Babler MartinPrincipia Biopharma Inc.
Baeuerle PatrickHarpoon Therapeutics, Inc.
BAILES JOSEPH SHarpoon Therapeutics, Inc.
Baker Bros. Advisors (GP) LLCPrincipia Biopharma Inc.
BAKER BROS. ADVISORS LPPrincipia Biopharma Inc.
BAKER FELIXPrincipia Biopharma Inc.
BAKER JULIANPrincipia Biopharma Inc.
Becker Daniel J.Principia Biopharma Inc.
BIOTECHNOLOGY VALUE FUND II LPPrincipia Biopharma Inc.
BIOTECHNOLOGY VALUE FUND L PPrincipia Biopharma Inc.
Biotechnology Value Trading Fund OS LPPrincipia Biopharma Inc.
Bucher James BHarpoon Therapeutics, Inc.
BVF GP HOLDINGS LLCPrincipia Biopharma Inc.
BVF I GP LLCPrincipia Biopharma Inc.
BVF II GP LLCPrincipia Biopharma Inc.
BVF INC/ILPrincipia Biopharma Inc.
BVF PARTNERS L P/ILPrincipia Biopharma Inc.
BVF Partners OS Ltd.Principia Biopharma Inc.
CHAI CHRISTOPHER YPrincipia Biopharma Inc.
Chin MarkHarpoon Therapeutics, Inc.
DRACHMAN JONATHAN GHarpoon Therapeutics, Inc.
EASTLAND JULIA MARIEHarpoon Therapeutics, Inc.
Erbez GeorgiaHarpoon Therapeutics, Inc.
EVNIN LUKEHarpoon Therapeutics, Inc.
Foley ToddHarpoon Therapeutics, Inc.
GADICKE ANSBERTHarpoon Therapeutics, Inc.
George SimeonPrincipia Biopharma Inc.
GLAXOSMITHKLINE PLCPrincipia Biopharma Inc.
Goldstein DavidPrincipia Biopharma Inc.
Gourlay StevePrincipia Biopharma Inc.
Hardiman Roy C.Principia Biopharma Inc.
HEALY JAMESPrincipia Biopharma Inc.
HUNT RONALDHarpoon Therapeutics, Inc.
LAMPERT MARK NPrincipia Biopharma Inc.
Lanza Frank JHarpoon Therapeutics, Inc.
Lathi Vijay KHarpoon Therapeutics, Inc.
Lin Shao-LeePrincipia Biopharma Inc.
Machado Clarence PatrickPrincipia Biopharma Inc.
McMahon Gerald PhDHarpoon Therapeutics, Inc.
Mehra AnandPrincipia Biopharma Inc.
Merck & Co., Inc.Harpoon Therapeutics, Inc.
MERCK & CO INCHarpoon Therapeutics, Inc.
Morgenthaler Management Partners IX, LLCPrincipia Biopharma Inc.
MORGENTHALER VENTURE PARTNERS IX LPPrincipia Biopharma Inc.

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →